CFO Annette Colin leaves Boule due to family reasons

Annette Colin has today informed Boule Diagnostics that she is leaving the position as CFO due to family reasons.

Annette will continue in her role during her six-month notice period in order to ensure an orderly transition period up until a new CFO assumes the position. The company will now initiate the recruitment of a successor.

“It is regrettable that Annette chooses to leave Boule for family reasons, but it is understandable, and I wish her all the best in the future.” says President and CEO Jesper Söderqvist.

For more information, please contact:
Jesper Söderqvist, CEO and Group President, Boule Diagnostics AB, phone +46 (0)70-689 05 90
Annette Colin, CFO, Boule Diagnostics AB, phone +46 (0)70-319 06 76

About Boule Diagnostics AB (publ)
Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.

This information is information that Boule Diagnostics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
The information was submitted for publication, through the agency of the contact person set out above, at 22:00 CET on August 4th, 2022.

Boule Diagnostics AB – CFO Annette Colin leaves Boule due to family reasons

  • Subscribe to our news